electroCore (ECOR) announced that it has received five patent issue notifications from the United States Patent and Trademark Office, USPTO. The five patents have been issued between December 17, 2024, and December 31, 2024: US Patent No. 12,168,128 entitled “Systems and Methods for Treating a Medical Condition” was issued on December 17, 2024; US Patent No. 12,168,121 entitled “Devices and Methods for Treating or Preventing Developmental Disorders” was issued on December 17, 2024; US Patent No. 12,172,015 entitled “Systems and Methods for Initial Provisioning and Refilling of Medical Devices” was issued on December 24, 2024; US Patent No. 12,172,016 entitled “Non-Invasive Electrical Stimulation for Medical Disorders” was issued on December 24, 2024; US Patent No. 12,179,012 entitled “Devices and Methods for Non-Invasive Nerve Stimulation” was issued on December 31, 2024.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ECOR:
- electroCore price target raised to $25 from $22 at H.C. Wainwright
- Electrocore to Acquire NeuroMetrix Enhancing Bioelectronic Offerings
- electroCore to acquire NeuroMetrix
- electroCore donates gammaCore Sapphire for real world evalution of nVNS
- electroCore price target raised to $22 from $15 at H.C. Wainwright